Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunnar Lohm

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers of Radiation Therapy and Oncology|June 12, 2008
Radiotherapy in biochemical recurrences after surgery for prostate cancerStefan Höcht, Gunnar Lohm, Lutz Moser, et al.
Radiation Oncology (London, England)|July 16, 2026
Prone versus supine radiotherapy for right-sided breast cancer - a retrospective study of radiotherapy plansGunnar Lohm, Konrad Neumann, Nina Thieß, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 20, 2017
Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progressionGunnar Lohm, Konrad Neumann, Volker Budach, et al.
Cancers|February 10, 2024
Salvage Radiotherapy for Relapsed Prostate Cancer after Radical Prostatectomy Is Associated with Normal Life ExpectancyGunnar Lohm, Franz Knörnschild, Konrad Neumann, et al.
World Journal of Urology|March 31, 2012
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable resultsGunnar Lohm, Dirk Bottke, Basil Jamil, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2011
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective studyAlessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 2014
Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy : Long-term follow-up of a single-center surveyGunnar Lohm, Jörg Lütcke, Basil Jamil, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2011
Salvage radiotherapy after prostatectomy - what is the best time to treat?Alessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2008
Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective studyThomas Wiegel, Gunnar Lohm, Dirk Bottke, et al.
Experimental Hematology & Oncology|December 6, 2012
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapseThomas Burmeister, Mara Molkentin, Claus Meyer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers of Radiation Therapy and Oncology|June 12, 2008
Radiotherapy in biochemical recurrences after surgery for prostate cancerStefan Höcht, Gunnar Lohm, Lutz Moser, et al.
Radiation Oncology (London, England)|July 16, 2026
Prone versus supine radiotherapy for right-sided breast cancer - a retrospective study of radiotherapy plansGunnar Lohm, Konrad Neumann, Nina Thieß, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 20, 2017
Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progressionGunnar Lohm, Konrad Neumann, Volker Budach, et al.
Cancers|February 10, 2024
Salvage Radiotherapy for Relapsed Prostate Cancer after Radical Prostatectomy Is Associated with Normal Life ExpectancyGunnar Lohm, Franz Knörnschild, Konrad Neumann, et al.
World Journal of Urology|March 31, 2012
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable resultsGunnar Lohm, Dirk Bottke, Basil Jamil, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2011
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective studyAlessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 2014
Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy : Long-term follow-up of a single-center surveyGunnar Lohm, Jörg Lütcke, Basil Jamil, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2011
Salvage radiotherapy after prostatectomy - what is the best time to treat?Alessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2008
Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective studyThomas Wiegel, Gunnar Lohm, Dirk Bottke, et al.
Experimental Hematology & Oncology|December 6, 2012
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapseThomas Burmeister, Mara Molkentin, Claus Meyer, et al.
Pageof 1